JOHN CIKA: Open Payments
NPI 1174246326 · STEUBENVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 22 payments from 9 companies in 2025. Trend: 2023 $365 · 2024 $486 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $187 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $83 |
| Novo Nordisk Inc | 3 | $52 |
| AKEBIA THERAPEUTICS INC | 2 | $43 |
| Travere Therapeutics, Inc. | 2 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Kerendia, JARDIANCE, Vafseo, Wegovy, LOKELMA, FUROSCIX, ACTHAR, Rybelsus.
Industry payments across OH — which companies pay providers there.
